Investment Stage

Focus Areas

About Investor

Guy Harmelin is an investor based in London with typical investment ranges between $750K - $10.0M. Dr. Harmelin currently serves as Chief Investment Officer for Advanced Technology at MGX and has extensive experience in healthcare and technology investment and entrepreneurship. He was previously on the leadership team at Harel Insurance and has served as a senior advisor to the CEO of Group 42 and to CIM Group, a US based real asset manager with over $30 billion in AUM. Guy also serves as a non-executive director on the board of Oxford Nanopore Technologies, bringing his extensive investment and technology expertise to guide the company's strategic direction. His background combines deep technical knowledge with extensive investment experience across multiple sectors.